Evidence map›Paper›PMID 35879423›Full record

ArticleScientific reports2022

Cholesterol affects the relationship between albumin and major adverse cardiac events in patients with coronary artery disease: a secondary analysis.

Yu-Feng Yao, Zhen-Yu Chen, Tian-Yi Luo, Xiao-Yan Dou, Hai-Bo Chen

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
2.3field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 15 citations in OpenAlex.

  1. Article
  2. Article
  3. Observational
  4. Article
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Yu-Feng Yao *Department of Ophthalmology, Shenzhen Second People's Hospital, Shenzhen, 518035, Guangdong Province, China.
Zhen-Yu Chen *Department of Cardiovascular Medicine, Shenzhen Second People's Hospital, Shenzhen, 518035, Guangdong Province, China.
Tian-Yi LuoDepartment of Ophthalmology, Shenzhen Second People's Hospital, Shenzhen, 518035, Guangdong Province, China.
Xiao-Yan DouDepartment of Ophthalmology, Shenzhen Second People's Hospital, Shenzhen, 518035, Guangdong Province, China. douxy08@163.com.
Hai-Bo ChenDepartment of Cardiovascular Medicine, Shenzhen Second People's Hospital, Shenzhen, 518035, Guangdong Province, China. hb901@126.com.
Shenzhen Second People's Hospital · CNShantou University Medical College · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

We aimed to examine whether the efficacy of the risk of poor prognosis in patients with coronary artery disease is jointly affected by total cholesterol and baseline serum albumin in a secondary analysis of previous study. We analyzed the data of 204 patients from October 2014 to October 2017 for newly diagnosed stable CAD. The outcome was major adverse cardiac events (MACE; defined as all cause mortality, non fatal myocardial infarction, and non fatal stroke). The median duration of follow-up was 783 days. Multivariable COX model was performed to revalidate the relationship between the sALB and MACE and interaction tests were conducted to find the effects of total cholesterol on their association. A total of 28 MACE occurred among the 204 participants. The risk of MACE varied by baseline serum albumin and total cholesterol. Specifically, lower serum albumin indicated higher risk of MACE (HR 3.52, 95% CI 1.30-9.54), and a test for interaction between baseline serum albumin and total cholesterol on MACE was significant (P = 0.0005). We suggested that baseline serum albumin and total cholesterol could interactively affect the risk of poor prognosis of patients with coronary artery diseases. Our findings need to be confirmed by further randomized trials.

Indexed as

Coronary Artery DiseaseMyocardial InfarctionCholesterolHumansPredictive Value of TestsPrognosisRisk FactorsSerum AlbuminCholesterolSerum Albumin

Identifiers

PMID35879423
PMCPMC9314340
OpenAlexW4287306938

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.